与 «ANTIEMETIC»相关的英语书籍
在以下的参考文献中发现
antiemetic的用法。与
antiemetic相关的书籍以及同一来源的简短摘要提供其在 英语文献中的使用情境。
Whereas this book should serve the clinician in making the right choice for every patients need, it also pays significant attention to the interests of scientists in the fields of oncology, nutrition, gastroenterology, obstetrics and ...
2
Perugia Consensus Conference on
Antiemetic Therapy
This volume contains the results of the fifth Perugia International Cancer Conference which was organized by the anti-emetic subcommittee of MASCC (Multinational Association of Supportive Care in Cancer).
Richard J. Gralla, Maurizio Tonato, Fausto Roila, 2011
3
Antiemetic - Antivertigo Agents—Advances in Research and ...
The editors have built Antiemetic - Antivertigo Agents—Advances in Research and Application: 2013 Edition on the vast information databases of ScholarlyNews.™ You can expect the information about ZZZAdditional Research in this book to ...
4
Economic Evaluation of Prophylactic
Antiemetic Regimens for ...
New antiemetic agents, aprepitant and palonosetron have been approved for prevention of chemotherapy-induced nausea and vomiting (CINV).
5
Holland Frei Cancer Medicine Eight
Waun Ki Hong, American Association for Cancer Research, William Hait.
Antiemetic Therapy Aditya Bardia, MBBS, MPH David S. Ettinger, MD Table 123-
1 Emetogenic Potential of Single Antineoplastic Agents Table 123-2. 123
Overview ...
Waun Ki Hong, American Association for Cancer Research, William Hait, 2010
6
Principles of Clinical Gastroenterology
Several antiemetic regimens have been proposed to prevent or control PONV. A
systematic review of 737 studies in 103 237 subjects concluded that prophylactic
antiemetic therapy provides benefit for 28% of patients whereas 1%-5% ...
7
Pediatric Oncology Nursing: Advanced Clinical Handbook ; 203 ...
Initial antiemetic selection based on emetogenicity of chemotherapeutic regimen
(Roy and Griffiths, 2003) Table 1 5.6. Other antiemetics used in paediatric
oncology Classiftcation/antiemetic Indications Benzodiazepine Lorazepam Oral ...
Deborah Tomlinson, Nancy E. Kline, 2005
8
Gastroparesis: Pathophysiology, Presentation and Treatment
Prokinetic. Agents. with. Antiemetic. Effects. Prokinetic medications are the
agents considered to be the first-line therapy for gastroparesis, based on their
abilities to accelerate delayed gastric emptying. However, there is limited
evidence ...
Henry P. Parkman, Richard W. McCallum, 2011
9
Psychiatric Aspects of Symptom Management in Cancer Patients
In general, the approach to the control of emesis is symptomatic, using antiemetic
drugs. In the setting of terminal illness, in which comfort is the goal of therapy, it is
sometimes quite difficult to determine how much investigation of the etiology of ...
William Breitbart, Jimmie C. Holland, 1993
10
Design and Evaluation of Orally Disintegrating Tablet of ...
The bitter taste of the drug was masked by Kyron T 114, a weak cation exchange resins with the method of ion exchange resin complexation, Which was prepared by the batch technique and various parameters (i.e. resin ratio, pH, Temperature, ...
Poraskumar Patel, Kunal Patel, Bhavanaben Patel, 2012
包含词语«ANTIEMETIC»的新条目
找出国内和国际出版社所讨论的内容，以及词语
antiemetic在以下新条目的上下文中是如何使用的。
Adding Aprepitant Improves Control of Oxaliplatin-Related Nausea …
Adding an NK1 antagonist (aprepitant or fosaprepitant) to a 5-HT3 receptor antagonist with dexamethasone improved antiemetic control for ... «OncLive, 七月 15»
NK1 Antagonist Shows Promising Results for Emesis Prevention
“We found that the three-drug combination antiemetic therapy of aprepitant, a 5-HT3-receptor antagonist and dexamethasone significantly ... «Cancer Network, 七月 15»
Active Stocks News Review: Allegheny Technologies, (NYSE:ATI …
EMEND for Injection, a substance P/Neurokinin-1 (NK1) receptor antagonist approved for use in combination with other antiemetic agents, ... «wsnewspublishers, 七月 15»
Active Stocks News Update: bluebird bio Inc (NASDAQ:BLUE), Insys …
... and vomiting associated with cancer chemotherapy in patients who have failed to respond adequately to conventional antiemetic treatments. «wsnewspublishers, 七月 15»
Evaluation of NK1 antagonists for emesis prevention in oxaliplatin …
"We found that the three-drug combination antiemetic therapy of aprepitant, a 5-HT3 receptor antagonist and dexamethasone significantly ... «Medical Xpress, 七月 15»
Merck's phase 3 study of single-dose Emend for injection regimen …
Emend for injection, approved for use in combination with other antiemetic agents, is indicated in adults for the prevention of acute and delayed ... «pharmabiz.com, 七月 15»
Pre-Market News Buzz on: AT&T, (NYSE:T), Merck & Co., (NYSE …
EMEND for Injection, a substance P/Neurokinin-1 (NK1) receptor antagonist approved for use in combination with other antiemetic agents, ... «wsnewspublishers, 六月 15»
Zoetis Inc. (NYSE:ZTS) received a takeover bid from Canadian drug …
... oncology, antiemetic, allergy, and dermatology products, as well as reproductive products. The company markets its products to veterinarians ... «Inside Trade, 六月 15»
FDA: Antiemetic Shortage Announced
FDA: Antiemetic Shortage Announced. The Food and Drug Administration (FDA) announced that Emend (aprepitant; Merck) is currently in ... «Monthly Prescribing Reference, 六月 15»
Merck's EMEND successful in late stage CINV study in moderately …
EMEND, a substance P/Neurokinin -1 receptor antagonist, is currently cleared in the U.S., in combination with other antiemetic agents, for the ... «Seeking Alpha, 六月 15»
